| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |